Last week’s top five stocks that reached their 52-week lows were Cisco Systems, Merck and Co, Abbott Labs, Amgen, and China Life Insurance Company. According to GuruFocus updates, these Guru stocks have reached their 52-week lows.
Cisco Systems Inc. (CSCO, Financial) Reached the 52-Week Low of $18.85
The prices of Cisco Systems Inc. (CSCO) shares have declined to close to the 52-week low of $18.85, which is 32.6% off the 52-week high of $27.57. Cisco Systems Inc. is owned by 37 Gurus we are tracking. Among them, 21 have added to their positions during the past quarter. 14 reduced their positions.
Cisco Systems, Inc. is the worldwide leader in networking for the Internet. Cisco Systems Inc. has a market cap of $104.48 billion; its shares were traded at around $18.85 with a P/E ratio of 13.18 and P/S ratio of 2.61. Cisco Systems Inc. had an annual average earning growth of 23% over the past 10 years. GuruFocus rated Cisco Systems Inc. the business predictability rank of 2.5-star.
Cisco recently reported its fourth quarter and fiscal year results for the period ended July 31, 2010. Cisco reported fourth quarter net sales of $10.8 billion, net income on a generally accepted accounting principles (GAAP) basis of $1.9 billion or $0.33 per share, and non-GAAP net income of $2.5 billion or $0.43 per share.
Donald Yacktman bought 5,359,709 shares in the quarter that ended on 12/31/2010, which is 1.82% of the $5.96 billion portfolio of Yacktman Asset Management Co.. Edward Lampert bought 6,439,720 shares in the quarter that ended on 12/31/2010, which is 1.41% of the $9.25 billion portfolio of ESL Investments. Private Capital bought 850,500 shares in the quarter that ended on 12/31/2010, which is 1.16% of the $1.48 billion portfolio of Private Capital Management. Joel Greenblatt bought 41,937 shares in the quarter that ended on 12/31/2010, which is 0.28% of the $306 million portfolio of Gotham Capital.
Sell: EVP, Ops, Processes & Systems Randall E Pond sold 200,000 shares of CSCO stock on 01/05/2011 at the average price of 20.7. Randall E Pond owns at least 574,607 shares after this. The price of the stock has decreased by 8.94% since. Other insiders have decreased their positions in the company.
MERCK & CO. INC. (MRK, Financial) Reached the 52-Week Low of $32.85
The prices of MERCK & CO. INC. (MRK) shares have declined to close to the 52-week low of $32.85, which is 17.4% off the 52-week high of $38.5. MERCK & CO. INC. is owned by 33 Gurus we are tracking. Among them, 11 have added to their positions during the past quarter. 17 reduced their positions.
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Merck & Co. Inc. has a market cap of $101.21 billion; its shares were traded at around $32.85 with a P/E ratio of 9.61 and P/S ratio of 2.2. The dividend yield of Merck & Co. Inc. stocks is 4.63%.
Merck recently announced financial results for the fourth quarter and full year of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.88, which excludes purchase accounting adjustments, restructuring costs and merger-related expenses. The purchase accounting adjustments include a $1.7 billion pre-tax charge related to its vorapaxar clinical research program.
Mario Gabelli owns 911,900 shares as of 12/31/2010, an increase of 17.54% from the previous quarter. This position accounts for 0.12% of the $26.72 billion portfolio of GAMCO Investors. George Soros owns 6,500 shares as of 12/31/2010, a decrease of 40.91% of from the previous quarter. This position accounts for less than 0.01% of the $7.69 billion portfolio of Soros Fund Management LLC. NWQ Managers owns 7,130,988 shares as of 12/31/2010, a decrease of 42.65% of from the previous quarter. This position accounts for 1.34% of the $19.36 billion portfolio of NWQ Investment Management Co.
ABBOTT LABORATORIES (ABT, Financial) Reached the 52-Week Low of $46.88
The prices of ABBOTT LABORATORIES (ABT) shares have declined to close to the 52-week low of $46.88, which is 18.7% off the 52-week high of $55.54. ABBOTT LABORATORIES is owned by 27 Gurus we are tracking. Among them, 15 have added to their positions during the past quarter. 8 reduced their positions.
Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott Laboratories has a market cap of $72.47 billion; its shares were traded at around $46.88 with a P/E ratio of 11.24 and P/S ratio of 2.06. The dividend yield of Abbott Laboratories stocks is 3.75%. Abbott Laboratories had an annual average earning growth of 7.3% over the past 10 years. GuruFocus rated Abbott Laboratories the business predictability rank of 4.5-star.
Abbott Labs recently reported its fourth quarter 2010 results. Diluted earnings per share, excluding specified items, were $1.30, reflecting 10.2 percent growth. Diluted earnings per share under Generally Accepted Accounting Principles (GAAP) were $0.92, primarily reflecting costs associated with recently announced restructuring actions for the integration of the Solvay Pharmaceuticals acquisition and in-process R&D related to the Reata collaboration.
Joel Greenblatt bought 11,494 shares in the quarter that ended on 12/31/2010, which is 0.18% of the $306 million portfolio of Gotham Capital. Richard Snow bought 59,733 shares in the quarter that ended on 12/31/2010, which is 0.11% of the $2.58 billion portfolio of Snow Capital Management, L.P.. Kenneth Fisher owns 15,070 shares as of 12/31/2010, which accounts for less than 0.01% of the $35.88 billion portfolio of Fisher Asset Management, LLC.
Buy: Director Phebe N Novakovic bought 500 shares of ABT stock on 12/06/2010 at the average price of 46.85. Phebe N Novakovic owns at least 500 shares after this. The price of the stock has increased by 0.06% since. Other insiders have decreased their positions in the company.
Amgen Inc. (AMGN, Financial) Reached the 52-Week Low of $52.24
The prices of Amgen Inc. (AMGN) shares have declined to close to the 52-week low of $52.24, which is 17.6% off the 52-week high of $61.14. Amgen Inc. is owned by 25 Gurus we are tracking. Among them, 12 have added to their positions during the past quarter. 11 reduced their positions.
Amgen Inc. discovers, develops and delivers innovative human therapeutics. Amgen Inc. has a market cap of $49.36 billion; its shares were traded at around $52.24 with a P/E ratio of 10.18 and P/S ratio of 3.28. Amgen Inc. had an annual average earning growth of 16.4% over the past 10 years. GuruFocus rated Amgen Inc. the business predictability rank of 3-star.
Amgen recently reported its fourth quarter 2010 results. Total revenue increased 1 percent during the fourth quarter of 2010 to $3,841 million versus $3,809 million in the fourth quarter of 2009. For the full year 2010, total revenue increased 3 percent to $15,053 million from $14,642 million in 2009.
Joel Greenblatt bought 4,304 shares in the quarter that ended on 12/31/2010, which is 0.08% of the $306 million portfolio of Gotham Capital. George Soros owns 11,100 shares as of 12/31/2010, an increase of 131.25% from the previous quarter. This position accounts for 0.01% of the $7.69 billion portfolio of Soros Fund Management LLC. Kenneth Fisher owns 14,091 shares as of 12/31/2010, an increase of 32.71% from the previous quarter. This position accounts for less than 0.01% of the $35.88 billion portfolio of Fisher Asset Management, LLC.
Sell: Sr. V.P. Human Resources Brian M Mcnamee sold 5,000 shares of AMGN stock on 02/01/2011 at the average price of 55.8. Brian M Mcnamee owns at least 33,559 shares after this. The price of the stock has decreased by 6.38% since. Other insiders have also decreased their positions in the company.
CHINA LIFE INSURANCE COMPANY LTD. (LFC, Financial) Reached the 52-Week Low of $58.13
The prices of CHINA LIFE INSURANCE COMPANY LTD. (LFC) shares have declined to close to the 52-week low of $58.13, which is 24.2% off the 52-week high of $74.79. CHINA LIFE INSURANCE COMPANY LTD. is owned by 7 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 6 reduced their positions.
China Life Insurance Company Limited is the life insurance company in China's life insurance market. China Life Insurance Company Ltd. has a market cap of $28.84 billion; its shares were traded at around $58.13 with a P/E ratio of 19.71 and P/S ratio of 0.58. The dividend yield of China Life Insurance Company Ltd. stocks is 2.35%. China Life Insurance Company Ltd. had an annual average earning growth of 73.6% over the past 5 years.
Chris Davis owns 390,313 shares as of 12/31/2010, which accounts for 0.04% of the $58.28 billion portfolio of Davis Selected Advisers. Kenneth Fisher owns 127,985 shares as of 12/31/2010, which accounts for 0.02% of the $35.88 billion portfolio of Fisher Asset Management, LLC.
Cisco Systems Inc. (CSCO, Financial) Reached the 52-Week Low of $18.85
The prices of Cisco Systems Inc. (CSCO) shares have declined to close to the 52-week low of $18.85, which is 32.6% off the 52-week high of $27.57. Cisco Systems Inc. is owned by 37 Gurus we are tracking. Among them, 21 have added to their positions during the past quarter. 14 reduced their positions.
Cisco Systems, Inc. is the worldwide leader in networking for the Internet. Cisco Systems Inc. has a market cap of $104.48 billion; its shares were traded at around $18.85 with a P/E ratio of 13.18 and P/S ratio of 2.61. Cisco Systems Inc. had an annual average earning growth of 23% over the past 10 years. GuruFocus rated Cisco Systems Inc. the business predictability rank of 2.5-star.
Cisco recently reported its fourth quarter and fiscal year results for the period ended July 31, 2010. Cisco reported fourth quarter net sales of $10.8 billion, net income on a generally accepted accounting principles (GAAP) basis of $1.9 billion or $0.33 per share, and non-GAAP net income of $2.5 billion or $0.43 per share.
Donald Yacktman bought 5,359,709 shares in the quarter that ended on 12/31/2010, which is 1.82% of the $5.96 billion portfolio of Yacktman Asset Management Co.. Edward Lampert bought 6,439,720 shares in the quarter that ended on 12/31/2010, which is 1.41% of the $9.25 billion portfolio of ESL Investments. Private Capital bought 850,500 shares in the quarter that ended on 12/31/2010, which is 1.16% of the $1.48 billion portfolio of Private Capital Management. Joel Greenblatt bought 41,937 shares in the quarter that ended on 12/31/2010, which is 0.28% of the $306 million portfolio of Gotham Capital.
Sell: EVP, Ops, Processes & Systems Randall E Pond sold 200,000 shares of CSCO stock on 01/05/2011 at the average price of 20.7. Randall E Pond owns at least 574,607 shares after this. The price of the stock has decreased by 8.94% since. Other insiders have decreased their positions in the company.
MERCK & CO. INC. (MRK, Financial) Reached the 52-Week Low of $32.85
The prices of MERCK & CO. INC. (MRK) shares have declined to close to the 52-week low of $32.85, which is 17.4% off the 52-week high of $38.5. MERCK & CO. INC. is owned by 33 Gurus we are tracking. Among them, 11 have added to their positions during the past quarter. 17 reduced their positions.
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Merck & Co. Inc. has a market cap of $101.21 billion; its shares were traded at around $32.85 with a P/E ratio of 9.61 and P/S ratio of 2.2. The dividend yield of Merck & Co. Inc. stocks is 4.63%.
Merck recently announced financial results for the fourth quarter and full year of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.88, which excludes purchase accounting adjustments, restructuring costs and merger-related expenses. The purchase accounting adjustments include a $1.7 billion pre-tax charge related to its vorapaxar clinical research program.
Mario Gabelli owns 911,900 shares as of 12/31/2010, an increase of 17.54% from the previous quarter. This position accounts for 0.12% of the $26.72 billion portfolio of GAMCO Investors. George Soros owns 6,500 shares as of 12/31/2010, a decrease of 40.91% of from the previous quarter. This position accounts for less than 0.01% of the $7.69 billion portfolio of Soros Fund Management LLC. NWQ Managers owns 7,130,988 shares as of 12/31/2010, a decrease of 42.65% of from the previous quarter. This position accounts for 1.34% of the $19.36 billion portfolio of NWQ Investment Management Co.
ABBOTT LABORATORIES (ABT, Financial) Reached the 52-Week Low of $46.88
The prices of ABBOTT LABORATORIES (ABT) shares have declined to close to the 52-week low of $46.88, which is 18.7% off the 52-week high of $55.54. ABBOTT LABORATORIES is owned by 27 Gurus we are tracking. Among them, 15 have added to their positions during the past quarter. 8 reduced their positions.
Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott Laboratories has a market cap of $72.47 billion; its shares were traded at around $46.88 with a P/E ratio of 11.24 and P/S ratio of 2.06. The dividend yield of Abbott Laboratories stocks is 3.75%. Abbott Laboratories had an annual average earning growth of 7.3% over the past 10 years. GuruFocus rated Abbott Laboratories the business predictability rank of 4.5-star.
Abbott Labs recently reported its fourth quarter 2010 results. Diluted earnings per share, excluding specified items, were $1.30, reflecting 10.2 percent growth. Diluted earnings per share under Generally Accepted Accounting Principles (GAAP) were $0.92, primarily reflecting costs associated with recently announced restructuring actions for the integration of the Solvay Pharmaceuticals acquisition and in-process R&D related to the Reata collaboration.
Joel Greenblatt bought 11,494 shares in the quarter that ended on 12/31/2010, which is 0.18% of the $306 million portfolio of Gotham Capital. Richard Snow bought 59,733 shares in the quarter that ended on 12/31/2010, which is 0.11% of the $2.58 billion portfolio of Snow Capital Management, L.P.. Kenneth Fisher owns 15,070 shares as of 12/31/2010, which accounts for less than 0.01% of the $35.88 billion portfolio of Fisher Asset Management, LLC.
Buy: Director Phebe N Novakovic bought 500 shares of ABT stock on 12/06/2010 at the average price of 46.85. Phebe N Novakovic owns at least 500 shares after this. The price of the stock has increased by 0.06% since. Other insiders have decreased their positions in the company.
Amgen Inc. (AMGN, Financial) Reached the 52-Week Low of $52.24
The prices of Amgen Inc. (AMGN) shares have declined to close to the 52-week low of $52.24, which is 17.6% off the 52-week high of $61.14. Amgen Inc. is owned by 25 Gurus we are tracking. Among them, 12 have added to their positions during the past quarter. 11 reduced their positions.
Amgen Inc. discovers, develops and delivers innovative human therapeutics. Amgen Inc. has a market cap of $49.36 billion; its shares were traded at around $52.24 with a P/E ratio of 10.18 and P/S ratio of 3.28. Amgen Inc. had an annual average earning growth of 16.4% over the past 10 years. GuruFocus rated Amgen Inc. the business predictability rank of 3-star.
Amgen recently reported its fourth quarter 2010 results. Total revenue increased 1 percent during the fourth quarter of 2010 to $3,841 million versus $3,809 million in the fourth quarter of 2009. For the full year 2010, total revenue increased 3 percent to $15,053 million from $14,642 million in 2009.
Joel Greenblatt bought 4,304 shares in the quarter that ended on 12/31/2010, which is 0.08% of the $306 million portfolio of Gotham Capital. George Soros owns 11,100 shares as of 12/31/2010, an increase of 131.25% from the previous quarter. This position accounts for 0.01% of the $7.69 billion portfolio of Soros Fund Management LLC. Kenneth Fisher owns 14,091 shares as of 12/31/2010, an increase of 32.71% from the previous quarter. This position accounts for less than 0.01% of the $35.88 billion portfolio of Fisher Asset Management, LLC.
Sell: Sr. V.P. Human Resources Brian M Mcnamee sold 5,000 shares of AMGN stock on 02/01/2011 at the average price of 55.8. Brian M Mcnamee owns at least 33,559 shares after this. The price of the stock has decreased by 6.38% since. Other insiders have also decreased their positions in the company.
CHINA LIFE INSURANCE COMPANY LTD. (LFC, Financial) Reached the 52-Week Low of $58.13
The prices of CHINA LIFE INSURANCE COMPANY LTD. (LFC) shares have declined to close to the 52-week low of $58.13, which is 24.2% off the 52-week high of $74.79. CHINA LIFE INSURANCE COMPANY LTD. is owned by 7 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 6 reduced their positions.
China Life Insurance Company Limited is the life insurance company in China's life insurance market. China Life Insurance Company Ltd. has a market cap of $28.84 billion; its shares were traded at around $58.13 with a P/E ratio of 19.71 and P/S ratio of 0.58. The dividend yield of China Life Insurance Company Ltd. stocks is 2.35%. China Life Insurance Company Ltd. had an annual average earning growth of 73.6% over the past 5 years.
Chris Davis owns 390,313 shares as of 12/31/2010, which accounts for 0.04% of the $58.28 billion portfolio of Davis Selected Advisers. Kenneth Fisher owns 127,985 shares as of 12/31/2010, which accounts for 0.02% of the $35.88 billion portfolio of Fisher Asset Management, LLC.
